2 results
Approved WMOPending
To assess the efficacy of inhaled RVT-1601 in comparison with placebo following 12 weeks of treatment
Approved WMOCompleted
To assess the influence of dosing guided by AutoK on achieving PK targets and clinical endpoints in intensive care patients with sepsis.